Back to Authors

Gonsalves, Wilson I.

https://orcid.org/0000-0001-6890-969X

A5068637846 | I1330342723

Mayo Clinic

Citations 414

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7237-7238

10.1182/blood-2022-169533

Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348

10.1182/blood-2022-167430

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10142-10143

10.1182/blood-2022-169046

Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999

10.1182/blood-2022-160368

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7315-7316

10.1182/blood-2022-164966

Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7141-7143

10.1182/blood-2022-163746

Immunoglobulin Heavy Chain Amyloidosis: Patient Characteristics and Outcomes

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8092-8093

10.1182/blood-2022-164617

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10068-10070

10.1182/blood-2022-162754

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019

10.1182/blood-2022-167181

Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7182-7184

10.1182/blood-2022-156078